Filtered By:
Infectious Disease: SARS
Drug: Acetylcysteine
This page shows you your search results in order of date.
Order by Relevance | Date
Total 29 results found since Jan 2013.
TWiV 1002: Clinical update with Dr. Daniel Griffin
In his weekly clinical update, Dr. Griffin discusses completeness and spin of medRxiv preprints and associated published abstracts of COVID-19 randomized clinical trials, lessons learned from a COVID-19 dog screening pilot in California K-12 schools, SARS-CoV-2 reinfection and severity of the disease, effectiveness of COVID-19 bivalent vaccine, Molnupiravir and risk of post-acute sequelae of COVID-19, risk of new-onset long Covid following reinfection with SARS-CoV-2, low vitamin D levels associated with long COVID syndrome in COVID-19 survivors, and clinical experience with the α2A-adrenoceptor agonist, guanfacine, an...
Source: This Week in Virology - MP3 Edition - April 29, 2023 Category: Virology Authors: VIncent Racaniello Source Type: podcasts
Role of Supplements in the Management of COVID-19 - A Comprehensive Review
Infect Disord Drug Targets. 2023 Mar 10. doi: 10.2174/1871526523666230310094646. Online ahead of print.ABSTRACTCoronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus-2 (SARS CoV-2) and patients with COVID-19 may be treated primarily with SARS CoV-2-targeting drugs and the therapeutic agents assisting in the management of COVID-19 complications. This review focuses on the supplements like vitamins, minerals, herbal constituents, and others that help prevent or manage negative outcomes among COVID-19 patients. The literature was searched in databases such as Medline/PubMed Central/...
Source: Infectious Disorders Drug Targets - March 10, 2023 Category: Infectious Diseases Authors: Rajkapoor Balasubramanian Naina Mohamed Pakkir Maideen Sudha Muthusamy Sambathkumar Ramanathan Mohamed Harsath Jahir Hussain Source Type: research
Nebulization of glutathione and N-Acetylcysteine as an adjuvant therapy for COVID-19 onset
Adv Redox Res. 2021 Dec;3:100015. doi: 10.1016/j.arres.2021.100015. Epub 2021 Aug 8.ABSTRACTEver since its emergence, the highly transmissible and debilitating coronavirus disease spread at an incredibly fast rate, causing global devastation in a matter of months. SARS-CoV-2, the novel coronavirus responsible for COVID-19, infects hosts after binding to ACE2 receptors present on cells from many structures pertaining to the respiratory, cardiac, hematological, neurological, renal and gastrointestinal systems. COVID-19, however, appears to trigger a severe cytokine storm syndrome in pulmonary structures, resulting in oxidati...
Source: Pain Physician - April 15, 2022 Category: Anesthesiology Authors: Jos é Fábio Santos Duarte Lana Anna Vit ória Santos Duarte Lana Qu ézia Souza Rodrigues Gabriel Silva Santos Riya Navani Annu Navani Lucas Furtado da Fonseca Gabriel Ohana Marques Azzini Thiago Setti Tomas Mosaner Claudio Lopes Simplicio Ta ís Mazzin Source Type: research
